Ir.wavelifesciences.com

  1. Home
  2. Ir.wavelifesciences.com

Reimagining RNA medicine

WEBWave receives upfront payment of $170 million in cash and equity, also eligible to receive milestone payments and royalties . Collaboration brings together …

Actived: 2 days ago

URL: https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-and-gsk-announce-collaboration-drive

Wave Life Sciences Highlights Growth Strategy for Building the …

WEBPresented preclinical proof-of-concept data for new, wholly owned program targeting INHBE for metabolic disorders, including obesity, which uses Wave’s best-in-class GalNAc …

Category:  Health Go Health

Reimagining RNA medicine

WEBWAVE LIFE SCIENCES LTD. UNAUDITED CONSOLIDATED BALANCE SHEETS (In thousands, except share amounts) December 31, 2022 December 31, 2021

Category:  Health Go Health

Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson …

WEBAppointment builds on Wave’s recent progress advancing innovative genetic targets, such as INHBE, and continues to add significant experience to accelerate the …

Category:  Health Go Health

Wave Life Sciences Highlights Recent Achievements and …

WEBCAMBRIDGE, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad …

Category:  Health Go Health

Wave Life Sciences Reports Fourth Quarter and Full Year 2023 …

WEBINHBE lead clinical candidate selected; potential best-in-class treatment for obesity with potent and durable silencing, weight loss with no loss of muscle mass, …

Category:  Health Go Health

Reimagining RNA Medicines

WEBOur RNA medicines platform, PRISM TM, combines multiple modalities, chemistry innovation, and deep insights in human genetics to deliver scientific …

Category:  Medicine Go Health

Reimagining RNA medicine

WEBReductions in poly(GP), a key disease biomarker indicating target engagement, observed across all treatment groups after single doses. Extending dose …

Category:  Health Go Health

Wave Life Sciences Announces Initiation of Dosing in …

WEBWVE-006 is uniquely designed to correct the disease-causing RNA mutation in AATD, thereby restoring circulation of wild-type M-AAT protein and reducing Z-AAT protein …

Category:  Health Go Health

Wave Life Sciences Announces Upcoming Presentations at MDA …

WEBPresentations include data for WVE-N531 that provide first clinical evidence of a potential therapeutic for DMD accessing satellite cells, which are important for …

Category:  Health Go Health

Wave Life Sciences to Present at Upcoming Investor Conferences

WEBCAMBRIDGE, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad …

Category:  Health Go Health

Wave Life Sciences to Present at 2024 RBC Capital Markets Global

WEBCAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad …

Category:  Health Go Health

Wave Life Sciences Announces Continued Momentum in GSK …

WEBGSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs …

Category:  Health Go Health

Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice …

WEBNewly created position will focus on translating advancements from PRISM platform into new therapeutic candidates. CAMBRIDGE, Mass., May 18, 2020 (GLOBE …

Category:  Health Go Health

Reimagining RNA medicine

WEBWave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials. March 29, 2021. PDF Version. mHTT results from PRECISION-HD trials do not …

Category:  Health Go Health

Wave Life Sciences to Present at the Cowen 39th Annual Health …

WEBCAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delivering …

Category:  Medicine Go Health

WAVE Life Sciences to Present at the Deutsche Bank 41st Annual …

WEBCAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 29, 2016-- WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company focused on developing …

Category:  Medicine Go Health

Wave Life Sciences Fourth Quarter and Full Year 2023 …

WEBWave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024 February 28, 2024 CAMBRIDGE, Mass. , Feb. 28, 2024 (GLOBE …

Category:  Health Go Health

Preclinical Data in Support of WVE-003, an Investigational …

WEB0 50 100 150 Relative HTT Expression (% of PBS) Cortex 0 50 100 150 Hippocampus Weeks HTT-2723 HTT-1533 (SNP3) PBS 4 8 12 4 8 12 4 8 12 Weeks HTT-2723 HTT …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › The maternal health task force

 › Does geico have health insurance

 › Healthier homemade one pot hamburger helper

 › Five points health care plans

 › Independent health claims log in

 › Health care for lgbtq

 › Quebec health card registration

 › Lumen health and benefits

 › Va medical facility inpatient mental health

 › Southeast health dothan menu

Recently Searched

 › Ripley county mo behavioral health clinic

 › Niagara health foundation donation policy

 › Healthiest cheeses for weight loss

 › Qualified health care letter michigan

 › Byram medical health care

 › Vita behavioral health contact number

 › Department of health services nc

 › Advent health bexley dr

 › Phil health konsulta provider registration

 › Rural health department wangaratta